BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27349009)

  • 1. Diagnostic Dilemma in the Detection of Antibodies to Filamentous Actin.
    Himoto T; Fujita K; Nomura T; Tani J; Miyoshi H; Morishita A; Yoneyama H; Haba R; Masaki T
    Clin Lab; 2016; 62(5):839-47. PubMed ID: 27349009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
    Villalta D; Bizzaro N; Da Re M; Tozzoli R; Komorowski L; Tonutti E
    Autoimmunity; 2008 Feb; 41(1):105-10. PubMed ID: 18176872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis.
    Granito A; Muratori L; Muratori P; Pappas G; Guidi M; Cassani F; Volta U; Ferri A; Lenzi M; Bianchi FB
    J Clin Pathol; 2006 Mar; 59(3):280-4. PubMed ID: 16505279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis.
    Frenzel C; Herkel J; Lüth S; Galle PR; Schramm C; Lohse AW
    Am J Gastroenterol; 2006 Dec; 101(12):2731-6. PubMed ID: 17227520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do autoantibodies predict autoimmune liver disease in primary Sjögren's syndrome? Data of 180 patients upon a 5 year follow-up.
    Csepregi A; Szodoray P; Zeher M
    Scand J Immunol; 2002 Dec; 56(6):623-9. PubMed ID: 12472675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
    Gabeta S; Norman GL; Liaskos C; Papamichalis PA; Zografos T; Garagounis A; Rigopoulou EI; Dalekos GN
    J Clin Immunol; 2007 Jul; 27(4):378-87. PubMed ID: 17514501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodies.
    Öztürk Ö; Dos Santos Duarte SD; Balaban HY; Şimşek H; Şener B
    Turk J Med Sci; 2022 Apr; 52(5):1697-1703. PubMed ID: 36422475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.
    Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
    J Autoimmun; 2018 Dec; 95():144-158. PubMed ID: 30366656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
    Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
    PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
    Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
    Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody Profiling in a Cohort of Pediatric and Adult Patients With Autoimmune Hepatitis.
    Villalta D; Girolami E; Alessio MG; Sorrentino MC; Tampoia M; Brusca I; Daves M; Porcelli B; Barberio G; Conte M; Pantarotto L; Bizzaro N;
    J Clin Lab Anal; 2016 Jan; 30(1):41-6. PubMed ID: 25242745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of humoral responses to the centromere proteins among HCV-related chronic liver disease, PBC and AIH patients.
    Himoto T; Tanaka N; Saito A; Muro Y; Sugiura K; Tani J; Miyoshi H; Morishita A; Yoneyama H; Haba R; Masaki T
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):222-9. PubMed ID: 25220385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis.
    Sobajima J; Ozaki S; Uesugi H; Osakada F; Inoue M; Fukuda Y; Shirakawa H; Yoshida M; Rokuhara A; Imai H; Kiyosawa K; Nakao K
    Gut; 1999 Jun; 44(6):867-73. PubMed ID: 10323891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of anti-F-actin antibodies in a French multicenter study.
    Chretien-Leprince P; Ballot E; Andre C; Olsson NO; Fabien N; Escande A; Oksman F; Dubuquoi S; Jego S; Goetz J; Chevailler A; Sanmarco M; Humbel RL; Johanet C
    Ann N Y Acad Sci; 2005 Jun; 1050():266-73. PubMed ID: 16014542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome.
    Muratori P; Granito A; Pappas G; Pendino GM; Quarneti C; Cicola R; Menichella R; Ferri S; Cassani F; Bianchi FB; Lenzi M; Muratori L
    Am J Gastroenterol; 2009 Jun; 104(6):1420-5. PubMed ID: 19491855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)].
    Kanzler S; Bozkurt S; Herkel J; Galle PR; Dienes HP; Lohse AW
    Dtsch Med Wochenschr; 2001 Apr; 126(16):450-6. PubMed ID: 11360449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-smooth muscle antibodies (ASMAs) and anti-cytoskeleton antibodies (ACTAs) in liver diseases: a comparison of classical indirect immunofluorescence with ELISA.
    Zamanou A; Tsirogianni A; Terzoglou C; Balafas A; Economidou I; Lymberi P
    J Clin Lab Anal; 2002; 16(4):194-201. PubMed ID: 12112392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.